363P Palbociclib exposure in relation to response and toxicity in patients with advanced breast cancer
Buijs, S.M., Ali, M.I. Mohmaed, Hoop, E. Oomen-de, Braal, C.L., Wortelboer, N., Van Ommen-Nijhof, A., Sonke, G.S., Konings, I.R., Jager, A., Steeghs, N., Siebinga, H., Mathijssen, R.H., Huitema, A.D.R., Koolen, S.L.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
278P Association between tamoxifen and endoxifen plasma levels and clotting proteins in patients with primary breast cancer
van Dorst, D., Buijs, S.M., Kruip, M.J.H.A., van den Akker, R.F.P., Cheung, K.L., Porrazzo, R., Hoop, E. Oomen-de, Jager, A., Koolen, S.L., Versmissen, J., Danser, J.A.H., Versteeg, H.H., Bos, M.H.A., Mathijssen, R.H.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
412P Phase I study of intraperitoneal irinotecan in combination with standard systemic chemotherapy in patients with extensive peritoneal metastases of colorectal origin: The INTERACT trial
Van Eerden, R.A.G., De Boer, N.L., van Kooten, J.P., Bakkers, C., Dietz, M.V., Creemers, G-J.M., Buijs, S.M., Bax, R., de Man, F.M., Lurvink, R.J., Diepeveen, M., Brandt-Kerkhof, A.R.M., van Meerten, E., Koolen, S.L., de Hingh, I.H.J.T., Verhoef, K., Mathijssen, R.H., Burger, P.W.A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer
Buijs, S.M., Hoop, E. Oomen-de, Braal, C.L., van Rosmalen, M.M., Drooger, J.C., van Rossum-Schornagel, Q.C., Vastbinder, M.B., Koolen, S.L.W., Jager, A., Mathijssen, R.H.J.
Published in ESMO open (01.02.2023)
Published in ESMO open (01.02.2023)
Get full text
Journal Article